Clinical Trial Update: Safety and Efficacy of Rifaximin in Patients With Papulopustular Rosacea and Positive Lactulose Breath Test [Phase 2]

View source ↗

Summary

Phase 2 trial update assessing safety and efficacy of rifaximin in patients with papulopustular rosacea and positive lactulose breath test.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Papulopustular Rosacea

Drugs mentioned

• Rifaximin (rifaximin)

Snippet

Sponsor: Alfasigma S.p.A. | Conditions: Papulopustular Rosacea | Phase 2 | Status: UNKNOWN